Skip to main content
SpringerLink
Log in

RPPA: Origins, Transition to a Validated Clinical Research Tool, and Next Generations of the Technology

  • Chapter
  • First Online:
Reverse Phase Protein Arrays

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 1188))

Abstract

RPPA technology has graduated from a research tool to an essential component of clinical drug discovery research and personalized medicine. Next generations of RPPA technology will be a single clinical instrument that integrates all the steps of the workflow.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Agarwal R, Gonzalez-Angulo AM, Myhre S, Carey M, Lee JS, Overgaard J, Alsner J, Stemke-Hale K, Lluch A, Neve RM, Kuo WL, Sorlie T, Sahin A, Valero V, Keyomarsi K, Gray JW, Borresen-Dale AL, Mills GB, Hennessy BT (2009) Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer. Clin Cancer Res 15:3654–3662

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Aguilar-Mahecha A, Cantin C, O’Connor-McCourt M, Nantel A, Basik M (2009) Development of reverse phase protein microarrays for the validation of clusterin, a mid-abundant blood biomarker. Proteome Sci 7:15

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Bailey CH, Jameson G, Sima C, Fleck S, White E, Von Hoff DD, Weiss GJ (2012) Progression-free survival decreases with each subsequent therapy in patients presenting for phase I clinical trials. J Cancer 3:7–13. PMID: 22211140

    Article  PubMed  Google Scholar 

  • Baldelli E et al (2015a) Functional signaling pathway analysis of lung adenocarcinomas identifies novel therapeutic targets for KRAS mutant tumors. Oncotarget 6(32):32368–32379

    Article  PubMed  PubMed Central  Google Scholar 

  • Baldelli E et al (2015b) Impact of upfront cellular enrichment by laser capture microdissection on protein and phosphoprotein drug target signaling activation measurements in human lung cancer: implications for personalized medicine. Proteomics Clin Appl 9(9–10):928–937

    Article  CAS  PubMed  Google Scholar 

  • Barker AD, Sigman CC, Kelloff GJ et al (2009) I-SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy. Clin Pharmacol Ther 86:97–100

    Article  CAS  PubMed  Google Scholar 

  • Belluco C, Mammano E, Petricoin E, Prevedello L, Calvert V, Liotta L, Nitti D, Lise M (2005) Kinase substrate protein microarray analysis of human colon cancer and hepatic metastasis. Clin Chim Acta 357:180–183

    Article  CAS  PubMed  Google Scholar 

  • Berry DA (2011) Adaptive clinical trials in oncology. Nat Rev Clin Oncol 9:199–207

    Article  PubMed  CAS  Google Scholar 

  • Berry DA (2015) The brave new world of clinical cancer research: adaptive biomarker-driven trials integrating clinical practice with clinical research. Mol Oncol 9:951–959

    Article  PubMed  PubMed Central  Google Scholar 

  • Canonici A, Gijsen M, Mullooly M et al (2013) Neratinib overcomes trastuzumab resistance in HER2amplified breast cancer. Oncotarget 4:1592–1605

    Article  PubMed  PubMed Central  Google Scholar 

  • Castagnoli L, Costantini A, Dall’Armi C, Gonfloni S, Montecchi-Palazzi L, Panni S, Paoluzi S, Santonico E, Cesareni G (2004) Selectivity and promiscuity in the interaction network mediated by protein recognition modules. FEBS Lett 567:74–79

    Article  CAS  PubMed  Google Scholar 

  • Celis JE, Gromov P (2003) Proteomics in translational cancer research: toward an integrated approach. Cancer Cell 3:9–15

    Article  CAS  PubMed  Google Scholar 

  • Corrãªa-Da-Silva MV (2013) Quantifying reduced glutathione by square-wave voltammetry. J Biosens Bioelectron 04(02). https://doi.org/10.4172/2155-6210.1000133

  • Dupuy L, Gauthier C, Durand G, Musnier A, Heitzler D, Herledan A, Sakanyan V, Crepieux P, Reiter E (2009) A highly sensitive near-infrared fluorescent detection method to analyze signalling pathways by reverse-phase protein array. Proteomics 9:5446–5454

    Article  CAS  PubMed  Google Scholar 

  • Ekins RP (1989) Multi-analyte immunoassay. J Pharm Biomed Anal 7:155–168

    Article  CAS  PubMed  Google Scholar 

  • Ekins RP, Chu FW (1991) Multianalyte microspot immunoassay--microanalytical “compact disk” of the future. Clin Chem 37:1955–1967

    CAS  PubMed  Google Scholar 

  • Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z, Goldstein SR, Weiss RA, Liotta LA (1996) Laser capture microdissection. Science 274:998–1001

    Article  CAS  PubMed  Google Scholar 

  • Espina V, Edmiston KH, Heiby M, Pierobon M, Sciro M, Merritt B, Banks S, Deng J, VanMeter AJ, Geho DH, Pastore L, Sennesh J, Petricoin EF 3rd, Liotta LA (2008) A portrait of tissue phosphoprotein stability in the clinical tissue procurement process. Mol Cell Proteomics 7:1998–2018

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Espina V, Mariani BD, Gallagher RI, Tran K, Banks S, Wiedemann J, Huryk H, Mueller C, Adamo L, Deng J, Petricoin EF III, Pastore L, Zaman S, Menezes G, Mize J, Johal J, Edmiston K, Liotta LA (2010) Malignant precursor cells pre-exist in human breast DCIS and require autophagy for survival. PLoS One 5:e10240

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Gonzalez-Angulo AM, Litton JK, Broglio KR, Meric-Bernstam F, Rakkhit R, Cardoso F, Peintinger F, Hanrahan EO, Sahin A, Guray M, Larsimont D, Feoli F, Stranzl H, Buchholz TA, Valero V, Theriault R, Piccart-Gebhart M, Ravdin PM, Berry DA, Hortobagyi GN (2009) High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2–positive, node-negative tumors 1 cm or smaller. J Clin Oncol 27(34):5700–5706

    Article  PubMed  PubMed Central  Google Scholar 

  • Grubb RL, Calvert VS, Wulkuhle JD, Paweletz CP, Linehan WM, Phillips JL, Chuaqui R, Valasco A, Gillespie J, Emmert-Buck M, Liotta LA, Petricoin EF (2003) Signal pathway profiling of prostate cancer using reverse phase protein arrays. Proteomics 3:2142–2146

    Article  CAS  PubMed  Google Scholar 

  • Gulmann C, Espina V, Petricoin E 3rd, Longo DL, Santi M, Knutsen T, Raffeld M, Jaffe ES, Liotta LA, Feldman AL (2005) Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma. Clin Cancer Res 11:5847–5855

    Article  CAS  PubMed  Google Scholar 

  • Haab BB, Dunham MJ, Brown PO (2001) Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol 2:RESEARCH0004.1-0004.13

    Article  Google Scholar 

  • Hauck TS, Giri S, Gao Y, Chan WC (2010) Nanotechnology diagnostics for infectious diseases prevalent in developing countries. Adv Drug Deliv Rev 62(4):438–448

    Article  CAS  PubMed  Google Scholar 

  • Haymond A, Dey D, Carter R, Dailing A, Nara V, Nara P, Venkatayogi S, Paige M, Liotta L, Luchini A (2019) Protein painting, an optimized MS-based technique, reveals functionally relevant interfaces of the PD-1/PD-L1 complex and the YAP2/ZO-1 complex. J Biol Chem 294:11180–11198

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hennessy BT, Gonzalez-Angulo A-M, Stemke-Hale K, Gilcrease MZ, Krishnamurthy S, Lee J-S, Fridlyand J, Sahin A, Agarwal R, Joy C, Liu W, Stivers D, Baggerly K, Carey M, Lluch A, Monteagudo C, He X, Weigman V, Fan C, Palazzo J, Hortobagyi GN, Nolden LK, Wang NJ, Valero V, Gray JW, Perou CM, Mills GB (2009) Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res 69:4116–4124

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Iyengar P, Espina V, Williams TW, Lin Y, Berry D, Jelicks LA, Lee H, Temple K, Graves R, Pollard J, Chopra N, Russell RG, Sasisekharan R, Trock BJ, Lippman M, Calvert VS, Petricoin EF 3rd, Liotta L, Dadachova E, Pestell RG, Lisanti MP, Bonaldo P, Scherer PE (2005) Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment. J Clin Invest 115:1163–1176

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jameson GS et al (2014) A pilot study utilizing multi-omic molecular profiling to find potential targets and select individualized treatments for patients with previously treated metastatic breast cancer. Breast Cancer Res Treat 147(3):579–588

    Article  CAS  PubMed  Google Scholar 

  • Janzi M, Ödling J, Pan-Hammarström Q, Sundberg M, Lundeberg J, Uhlén M, Hammarström L, Nilsson P (2005) Serum microarrays for large scale screening of protein levels. Mol Cell Proteomics 4(12):1942–1947

    Article  CAS  Google Scholar 

  • Janzi M, Sjoberg R, Wan J, Fischler B, von Dobeln U, Isaac L, Nilsson P, Hammarstrom L (2009) Screening for C3 deficiency in newborns using microarrays. PLoS One 4:e5321

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Jiang R, Mircean C, Shmulevich I, Cogdell D, Jia Y, Tabus I, Aldape K, Sawaya R, Bruner JM, Fuller GN, Zhang W (2006) Pathway alterations during glioma progression revealed by reverse phase protein lysate arrays. Proteomics 6:2964–2971

    Article  CAS  PubMed  Google Scholar 

  • Liotta L, Petricoin E (2000) Molecular profiling of human cancer. Nat Rev Genet 1(1):48–56

    Article  CAS  PubMed  Google Scholar 

  • Liotta LA, Espina V, Mehta AI, Calvert V, Rosenblatt K, Geho D, Munson PJ, Young L, Wulfkuhle J, Petricoin EF (2003) Protein microarrays: meeting analytical challenges for clinical applications. Cancer Cell 3:317–325

    Article  CAS  PubMed  Google Scholar 

  • Longo C, Patanarut A, George T, Bishop B, Zhou W, Fredolini C, Ross MM, Espina V, Pellacani G, Petricoin EF 3rd, Liotta LA, Luchini A (2009) Core-shell hydrogel particles harvest, concentrate and preserve labile low abundance biomarkers. PLoS One 4:e4763

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Luchini A, Geho DH, Bishop B, Tran D, Xia C, Dufour RL, Jones CD, Espina V, Patanarut A, Zhou W et al (2008) Smart hydrogel particles: biomarker harvesting: one-step affinity purification, size exclusion, and protection against degradation. Nano Lett 8:350–361

    Article  CAS  PubMed  Google Scholar 

  • Luchini A, Espina V, Liotta LA (2014) Protein painting reveals solvent-excluded drug targets hidden within native protein-protein interfaces. Nat Commun 5:4413

    Article  CAS  PubMed  Google Scholar 

  • MacBeath G, Schreiber SL (2000) Printing proteins as microarrays for high-throughput function determination. Science 289:1760–1763

    CAS  PubMed  Google Scholar 

  • Magni R, Luchini A (2017) Application of hydrogel nanoparticles for the capture, concentration, and preservation of low-abundance biomarkers. Methods Mol Biol 1606:103–113

    Article  CAS  PubMed  Google Scholar 

  • Mueller C, Zhou W, Vanmeter A, Heiby M, Magaki S, Ross MM, Espina V, Schrag M, Dickson C, Liotta LA, Kirsch WM (2010) The heme degradation pathway is a promising serum biomarker source for the early detection of Alzheimer’s disease. J Alzheimers Dis 19:1081–1091

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nishizuka S, Charboneau L, Young L, Major S, Reinhold WC, Waltham M, Kouros-Mehr H, Bussey KJ, Lee JK, Espina V, Munson PJ, Petricoin E 3rd, Liotta LA, Weinstein JN (2003) Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proc Natl Acad Sci U S A 100:14229–14234

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Park JW, Liu MC, Yee D et al (2016) Adaptive randomization of neratinib in early breast cancer. N Engl J Med 375:11–22

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Paweletz CP, Charboneau L, Bichsel VE, Simone NL, Chen T, Gillespie JW, Emmert-Buck MR, Roth MJ, Petricoin IE, Liotta LA (2001) Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 20:1981–1989

    Article  CAS  PubMed  Google Scholar 

  • Petricoin EF, Bichsel V, Calvert V, Espina V, Winters M, Young L, Belluco C, Steinberg S, Trock B, Lippman M, Fishman D, Sgroi D, Munson P, Esserman L, Liotta LA (2005) Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy. J Clin Oncol 23(15):3614–3621

    Article  CAS  PubMed  Google Scholar 

  • Petricoin EF 3rd, Espina V, Araujo RP, Midura B, Yeung C, Wan X, Eichler GS, Johann DJ Jr, Qualman S, Tsokos M, Krishnan K, Helman LJ, Liotta LA (2007) Phosphoprotein pathway mapping: Akt/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survival. Cancer Res 67:3431–3440

    Article  CAS  PubMed  Google Scholar 

  • Pierobon M et al (2015) Application of molecular technologies for phosphoproteomic analysis of clinical samples. Oncogene 34(7):805–814

    Article  CAS  PubMed  Google Scholar 

  • Posadas EM, Simpkins F, Liotta LA, MacDonald C, Kohn EC (2005) Proeteomic analysis for the early detection and rational treatment of cancer--realistic hope? Ann Oncol 16:16–22

    Article  CAS  PubMed  Google Scholar 

  • Ramaswamy A, Lin E, Chen I, Mitra R, Morrisett J, Coombes K, Ju Z, Kapoor M (2005) Application of protein lysate microarrays to molecular marker verification and quantification. Proteome Sci 3:9

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Romeo MJ, Wunderlich J, Ngo L, Rosenberg SA, Steinberg SM, Berman DM (2006) Measuring tissue-based biomarkers by immunochromatography coupled with reverse-phase lysate microarray. Clin Cancer Res 12:2463–2467

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sanchez-Carbayo M, Socci ND, Lozano J, Saint F, Cordon-Cardo C (2006) Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. J Clin Oncol 24(5):778–789

    Article  CAS  PubMed  Google Scholar 

  • Silvestri A, Colombatti A, Calvert VS, Deng J, Mammano E, Belluco C, De Marchi F, Nitti D, Liotta LA, Petricoin EF, Pierobon M (2010) Protein pathway biomarker analysis of human cancer reveals requirement for upfront cellular-enrichment processing. Lab Investig 90:787

    Article  CAS  PubMed  Google Scholar 

  • Spurrier B, Ramalingam S, Nishizuka S (2008) Reverse-phase protein lysate microarrays for cell signaling analysis. Nat Protoc 3:1796–1808

    Article  PubMed  Google Scholar 

  • Srivastava M, Eidelman O, Zhang J, Paweletz C, Caohuy H, Yang Q, Jacobson KA, Heldman E, Huang W, Jozwik C, Pollard BS, Pollard HB (2004) Digitoxin mimics gene therapy with CFTR and suppresses hypersecretion of IL-8 from cystic fibrosis lung epithelial cells. Proc Natl Acad Sci U S A 101:7693–7698

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tamburro D, Fredolini C, Espina V, Douglas TA, Ranganathan A, Ilag L, Zhou W, Russo P, Espina BH, Muto G et al (2011) Multifunctional core-shell nanoparticles: discovery of previously invisible biomarkers. J Am Chem Soc 133:19178–19188

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tibes R, Qiu Y, Lu Y, Hennessy B, Andreeff M, Mills GB, Kornblau SM (2006) Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells. Mol Cancer Ther 5:2512–2521

    Article  CAS  PubMed  Google Scholar 

  • Tran HV, Huynh CD, Tran HV, Piro B (2016) Cyclic voltammetry, square wave voltammetry, electrochemical impedance spectroscopy and colorimetric method for hydrogen peroxide detection based on chitosan/silver nanocomposite. Arab J Chem 11:453. https://doi.org/10.1016/j.arabjc.2016.08.007

    Article  CAS  Google Scholar 

  • VanMeter AJ, Rodriguez AS, Bowman ED, Jen J, Harris CC, Deng J, Calvert VS, Silvestri A, Fredolini C, Chandhoke V, Petricoin EF 3rd, Liotta LA, Espina V (2008) Laser capture microdissection and protein microarray analysis of human non-small cell lung cancer: differential epidermal growth factor receptor (EGFR) phosphorylation events associated with mutated EGFR compared with wild type. Mol Cell Proteomics 7:1902–1924

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wulfkuhle JD, Aquino JA, Calvert VS, Fishman DA, Coukos G, Liotta LA, Petricoin EF 3rd (2003) Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase protein microarrays. Proteomics 3:2085–2090

    Article  CAS  PubMed  Google Scholar 

  • Wulfkuhle JD, Speer R, Pierobon M, Laird J, Espina V, Deng J, Mammano E, Yang SX, Swain SM, Nitti D, Esserman LJ, Belluco C, Liotta LA, Petricoin EF 3rd (2008) Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy. J Proteome Res 7:1508–1517

    Article  CAS  PubMed  Google Scholar 

  • Wulfkuhle JD, Berg D, Wolff C et al (2012) Molecular analysis of HER2 signaling in human breast cancer by functional protein pathway activation mapping. Clin Cancer Res 18:6426–6435

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wulfkuhle et al (2016) Prediction of complete pathologic response to veliparib/carboplatin plus standard neoadjuvant therapy in her2 negative breast cancer: exploratory protein pathway marker results from the I-SPY 2 trial, San Antonio, TX

    Google Scholar 

  • Wulfkuhle J, Yau C, Wolf D, Vis D, Gallagher R, Brown-Swigart L, Hirst G, Voest E, DeMichele A, Hylton N, Symmans F, Yee D, Esserman L, Berry D, Liu M, Park J, Wessels L, van’t Veer L, Petricoin E (2018) Evaluation of the HER/PI3K/AKT family signaling network as a predictive biomarker of pathologic complete response for patients with breast cancer treated with Neratinib in the I-SPY 2 TRIAL. JCO Precis Oncol. 129.174.255.125

    Google Scholar 

  • Zhou J, Wulfkuhle J, Zhang H, Gu P, Yang Y, Deng J, Margolick JB, Liotta LA, Petricoin E, Zhang Y (2007) Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc Natl Acad Sci U S A 104:16158–16163

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, USA

    Emanuel Petricoin III, Julie Wulfkuhle, Marissa Howard, Marielena Pierobon, Virginia Espina, Alessandra Luchini & Lance A. Liotta

Authors
  1. Emanuel Petricoin III
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Julie Wulfkuhle
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marissa Howard
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marielena Pierobon
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Virginia Espina
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Alessandra Luchini
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Lance A. Liotta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lance A. Liotta .

Editor information

Editors and Affiliations

  1. Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan

    Tesshi Yamada

  2. Division of Biomedical, Research and Development, Institute of Biomedical Science, Iwate Medical University, Yahaba, Iwate, Japan

    Satoshi S. Nishizuka

  3. Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Gordon B. Mills

  4. Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, USA

    Lance A. Liotta

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Petricoin, E. et al. (2019). RPPA: Origins, Transition to a Validated Clinical Research Tool, and Next Generations of the Technology. In: Yamada, T., Nishizuka, S., Mills, G., Liotta, L. (eds) Reverse Phase Protein Arrays. Advances in Experimental Medicine and Biology, vol 1188. Springer, Singapore. https://doi.org/10.1007/978-981-32-9755-5_1

Download citation

Publish with us

Policies and ethics

Search

Navigation